PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
29375004-5	2019	Contributions of CYP3A4 and CYP2C9 to metabolism of deoxypodophyllotoxin and nateglinide were also predicted.	Nateglinide	77-88	cytochrome P450 family 3 subfamily A member 4	Homo sapiens	17-23	
29375004-8	2019	Predicted contributions of CYP3A4 and CYP2C9 to nateglinide metabolism were 8.18-37.84% and 36.08-94.04%, separately.	Nateglinide	48-59	cytochrome P450 family 3 subfamily A member 4	Homo sapiens	27-33	
18159128-1	2007	Nateglinide is an antidiabetic agent metabolized by CYP2C9 and CYP3A4; hence inhibitors of these CYP isozymes may interact with nateglinide.	Nateglinide	0-11	cytochrome P450 family 3 subfamily A member 4	Homo sapiens	63-69	
20609060-1	2010	OBJECTIVES: Nateglinide is metabolized by CYP2C9 and CYP3A4, therefore drug-drug interactions through cytochrome P450 (CYP) inhibition may occur.	Nateglinide	12-23	cytochrome P450 family 3 subfamily A member 4	Homo sapiens	53-59	
20609060-7	2010	The influence of pre-incubation on the inhibition by nateglinide of CYP3A4, CYP2C9 and CYP2C19 was examined.	Nateglinide	53-64	cytochrome P450 family 3 subfamily A member 4	Homo sapiens	68-74	
18159128-1	2007	Nateglinide is an antidiabetic agent metabolized by CYP2C9 and CYP3A4; hence inhibitors of these CYP isozymes may interact with nateglinide.	Nateglinide	128-139	cytochrome P450 family 3 subfamily A member 4	Homo sapiens	63-69	
16042675-3	2005	Our aim was to investigate the effects of the gemfibrozil-itraconazole combination on the pharmacokinetics and pharmacodynamics of another meglitinide analogue, nateglinide, which is metabolized by CYP2C9 and CYP3A4.	Nateglinide	161-172	cytochrome P450 family 3 subfamily A member 4	Homo sapiens	209-215	
16042675-0	2005	Coadministration of gemfibrozil and itraconazole has only a minor effect on the pharmacokinetics of the CYP2C9 and CYP3A4 substrate nateglinide.	Nateglinide	132-143	cytochrome P450 family 3 subfamily A member 4	Homo sapiens	115-121